Patent · US Active

Synthetic bi-epitope compound

US11193929B2 · kind B2 · utility

0Cited by

2References

7Claims

0Family size

Assignee

BIOMERIEUX, INC. · FR

Inventors

Florence Bettsworth · Château-Chinon, FR
Sandrine Busseret · Val-de-Reuil, FR
Catherine Pothion · Val-de-Reuil, FR

Key dates

Filing date	Dec 17, 2015
Grant date	Dec 7, 2021
Priority date	—
Expiry date	Jul 17, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/32
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A bi-epitope compound of formula I: in which: E1 and E2, identical or different, each separately represents a peptide sequence including at least one epitope of an analyte; X and Y, identical or different, each separately represents a linking arm, the carrier molecule is soluble and Z represents an amino acid derivative bearing a thiol function prior to the bonding of same with the carrier molecule. The compound may be contained in a composition, used as a control or standard in an immunoassay and associated method, and/or provided in a kit for implementing an immunoassay.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.